Our strategic partnerships and business development initiatives continually enhance our pipeline and technology portfolio,
ensuring that each partnership generates mutual value and accelerates scientific progress.
Through collaborative clinical development, we are advancing scientific innovation and expediting the translation of
promising transformational therapies into clinical practice to deliver meaningful benefits for patients.

We are also actively pursuing collaborations with leading academic medical centers globally,
recognizing their vital role in driving innovation and advancing scientific discovery.
Our ongoing and past partnerships have supported the research goals of our collaborators
while aligning with Ingenia’s long term strategic vision and advancing our pipeline and technology.

For academic collaborations, our policy is to limit indirect costs to a maximum of 36%.